Journal Article

Virtual biopsy using MRI radiomics for prediction of BRAF status in melanoma brain metastasis

Fanizzi, Claudia, Ram, Zvi, Grossman, Rachel, DiMeco, Francesco, Peleg Hason, Shira, Artzi, Moran, Shtrozberg, Shai, Shofty, Ben, Haim, Oz, Bashat, Dafna Ben

2020

Overview

Brain metastases are common in patients with advanced melanoma and constitute a major cause of morbidity and mortality. Between 40% and 60% of melanomas harbor BRAF mutations. Selective BRAF inhibitor therapy has yielded improvement in clinical outcome; however, genetic discordance between the primary lesion and the metastatic tumor has been shown to occur. Currently, the only way to characterize the genetic landscape of a brain metastasis is by tissue sampling, which carries risks and potential complications. The aim of this study was to investigate the use of radiomics analysis for non-invasive identification of BRAF mutation in patients with melanoma brain metastases, based on conventional magnetic resonance imaging (MRI) data. We applied a machine-learning method, based on MRI radiomics features for noninvasive characterization of the BRAF status of brain metastases from melanoma (BMM) and applied it to BMM patients from two tertiary neuro-oncological centers. All patients underwent surgical resection for BMM, and their BRAF mutation status was determined as part of their oncological work-up. Their routine preoperative MRI study was used for radiomics-based analysis in which 195 features were extracted and classified according to their BRAF status via a support vector machine. The BRAF status of 53 study patients, with 54 brain metastases (25 positive, 29 negative for BRAF mutation) was predicted with mean accuracy = 0.79 ± 0.13, mean precision = 0.77 ± 0.14, mean sensitivity = 0.72 ± 0.20, mean specificity = 0.83 ± 0.11 and with a 0.78 area under the receiver operating characteristic curve for positive BRAF mutation prediction. Radiomics-based noninvasive genetic characterization is feasible and should be further verified using large prospective cohorts.

• Publisher: Nature Publishing Group UK,Nature Publishing Group
• Subject: 59/57 / 631/378/1689/1690 / 692/699/67/2321 / Biopsy / Brain cancer / Brain Neoplasms - diagnostic imaging / Brain Neoplasms - secondary / Discordance / Female / Humanities and Social Sciences / Humans / Learning algorithms / Machine learning / Magnetic Resonance Imaging / Male / Melanoma / Melanoma - pathology / Metastases / Metastasis / Middle Aged / Morbidity / multidisciplinary / Mutation / Neuroimaging / Proto-Oncogene Proteins B-raf - genetics / Radiomics / ROC Curve / Science / Science (multidisciplinary) / Toxicity